MIR Biosimilars Market, Competitive Analysis | Page 2

ailments. Growing preference for biosimilars to treat chronic ailments is expected to further
propel the growth of the biosimilars market in the coming years.
Rise in Demand of Biosimilars Due to Cost--effectiveness
Over the years, the rise in demand of biosimilars has played a vital role in contributing to the
growth of the global biosimilars industry. The high demand for biosimilars is attributed to their
greater effectiveness and lower cost than other alternatives. Several countries, including Europe,
North America, India, and other developing countries, have emerged as essential contributors to
global biosimilars industry. While generic drugs have a profit margin potential of 20%, the
biosimilars products is anticipated to gain a potential profit margin of 30%. Moreover, cost of
treatment by innovator drug is much higher than that by biosimilars, which has also contributed
effectively to the growing demand of these products.
Get detailed report @ https://www.marketindustryreports.com/67/biosimilars-market
Some key points for TOC
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.2.1. Market Classification
1.2.2. Geographic Scope
1.2.3. Years Considered for the Study: Historical Years – 2016 & 2017; Base Year –
2018; Forecasted Years – 2019 to 2030
1.3. Currency Used
2. RESEARCH METHODOLOGY
2.1. Research Framework
2.2. Data Collection Technique
2.3. Data Sources
2.3.1. Secondary Sources
2.3.2. Primary Sources
2.4. Market Estimation Methodology
2.4.1. Bottoms Up Approach
2.4.2. Top Down Approach
2.5. Data Validation and Triangulation
2.5.1. Market Forecasting Model
2.5.2. Limitations/Assumptions of the Study
Buy report @ https://www.marketindustryreports.com/checkout/67
About Us
We offer our clients a unique depth of market intelligence in an actionable format to move their
business forward. Our analysis incorporates the consumer study in more than 100 countries that